Finance & Economy

Vipul Organics Raises ₹35.23 Cr via Preferential Allotment

Published on 
Author: DISHA PRAFUL SUKHANI

Company issues 16.7 lakh equity shares at ₹211 per share to 19 investors in non-promoter category.

Vipul Organics Limited successfully raises ₹35.23 crore through the preferential issue of 16.7 lakh equity shares, reinforcing investor confidence and supporting its expansion and sustainability plans.

Vipul Organics Limited, a leading BSE-listed specialty chemicals manufacturer in the pigments and dyes sector (BSE Code: 530627 / VIPULORG), has announced a successful fund-raise of ₹35.23 crore through a preferential allotment.

The company has issued 16,70,000 fully paid-up equity shares of face value ₹10 each at an issue price of ₹211 per share, which includes a premium of ₹201. The total funds raised through this preferential issue amount to ₹35,23,70,000. The issue was made to 19 investors under the non-promoter / non-promoter group category on a private placement basis.

Expressing optimism about the fundraise, Mr. Vipul P. Shah, Managing Director of Vipul Organics Limited, stated:

“The subscription of our Preferential Issue by HNIs reflects strong investor confidence in the company’s long-term vision. We remain committed to creating sustainable value for our stakeholders through innovation and business diversification. Our ongoing focus on de-risking operations and expanding into new product categories reinforces this goal. The proceeds from the issue will enable capacity expansion without additional debt. We are particularly enthusiastic about our new membrane technology venture and its potential contribution to India’s sustainability journey.”

The successful allotment marks another strategic step in Vipul Organics’ growth roadmap as it continues to strengthen its market presence and invest in future-ready technologies within the specialty chemicals space.

Subscribe to our Weekly E-Newsletter

Stay updated with the latest news, articles, and market reports, appointments, many more.

By subscribing you agree to our Terms and Privacy Policy.